7XF-80925-31330
2 vaccinations
3 coded responses
4 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 633 / MO
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Dose 2 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
-
2021-03-16
Survey response — day 7, dose 2MedDRA: Injection site pain, Injection site pruritus, Pre-existing disease, Rash, Self-medication — Feeling: Fair · Site: ItchingFree text: I have liver inflammation. After the second shot I awoke in middle of night to pain, burning sensation, and itch. It was at injection site. In morning the rash was spreading along with itch. I had to use lidocaine patches. Eventually it spread to both arms and chest. This week the rash went away. Pain is gone but itching still here but mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
-
2021-03-27
Survey response — day 21, dose 2MedDRA: Cyanosis — Feeling: FairFree text: My hands are blue. I dont know if it is associated or not.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-04
Survey response — 6 months, dose 2MedDRA: Atrial fibrillation, Gallbladder disorder, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Afib,tachcardia,gallbladder problemsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-09
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 5 — day 7, dose 2
Systemic reaction (other): I have liver inflammation. After the second shot I awoke in middle of night to pain, burning sensation, and itch. It was at injection site. In morning the rash was spreading along with itch. I had to use lidocaine patches. Eventually it spread to both arms and chest. This week the rash went away. Pain is gone but itching still here but mild.
Release 6 — day 21, dose 2
Symptoms: My hands are blue. I dont know if it is associated or not.
Release 9 — 6 months, dose 2
Symptoms: Afib,tachcardia,gallbladder problems
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Atrial fibrillation | ✓ | · | ✓ |
| SD | Cyanosis | ✓ | ✓ | ✓ |
| SD | Gallbladder disorder | ✓ | · | ✓ |
| SD | Tachycardia | ✓ | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release